<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20230730058968N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-09-05</date_registration>
      <primary_sponsor>Islamic Azad University</primary_sponsor>
      <public_title>Comparison of the effectiveness of transcranial direct electrical stimulation of the brain (tDCS) with cognitive rehabilitation in the treatment of drug addicts undergoing maintenance treatment.</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of the effectiveness of transcranial direct electrical stimulation of the brain (tDCS) with cognitive rehabilitation on selective attention, cognitive flexibility, response inhibition and craving in drug addicts undergoing maintenance treatment.</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-08-06</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>45</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/71660</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Health service research, Other design features: Due to the fact that in this study, the participants receive one of cognitive rehabilitation interventions or direct transcranial electrical stimulation of the brain, it was not possible to blind the participants, Randomization description: To allocate people in the study groups, the dice throwing method was used so that the numbers 1 and 2 are for the placement of people in the tDCS treatment group, the numbers 3 and 4 are for the placement of people in the cognitive rehabilitation group and the numbers 5 and 6 are for the placement of people in the the control group was defined, Blinding description: In this study, the members of the medical centers from which the patients were selected, as well as the two people who evaluated and completed the tools used in the research, were kept blind to the allocation of the study groups.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Addicts undergoing maintenance treatment.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: experimental group A will receive ten sessions of transcranial electric current stimulation. Intervention with OASIS PRO WITH tDCS device from MIND ALIVE company was used. Subjects in this group participated in treatment sessions every other day for ten sessions. Anode electrode was placed in the posterolateral region of the left prefrontal cortex and cathode electrode was placed in the posterolateral region of the right prefrontal cortex, and in each session for 20 minutes, a current of 2 milliamps of direct electric current was passed through the skull of the subjects. Intervention 2: Intervention group: The experimental group received ten sessions of cognitive rehabilitation, which used Nejati's cognitive rehabilitation computer program (2010), which includes strengthening working memory, strengthening selective attention, strengthening sustained attention, and strengthening transitional attention. It was performed in 10 sessions of 30 minutes and 3 sessions per week. Intervention 3: Control group: The control group will continue their usual treatment program and receive no other intervention.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
All data can be shared after de-identifying individuals

When:
Access starts 6 months after results are published

To whom:
The data will be available to researchers working in scientific and academic institutions

Conditions:
Data will be accessible for analyzes related to review studies and meta-analysis

Where to obtain:
To receive documents, you can contact researcher6411@gmail.com

How to obtain:
The authorized data file will be available to the applicants as soon as they see the message in the e-mail, within a week

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Somayeh Bagheri</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Islamic Azad University, Semnan Branch, Faculty of Humanities, Department of Psychology</address>
        <city>Semnan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3513137111</zip>
        <telephone>+98 23 3365 4231</telephone>
        <email>researcher6411@gmail.com</email>
        <affiliation>Islamic Azad University</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Somayeh Bagheri</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Islamic Azad University, Semnan Branch, Faculty of Humanities, Department of Psychology</address>
        <city>Semnan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3513137111</zip>
        <telephone>+98 23 3365 4231</telephone>
        <email>researcher6411@gmail.com</email>
        <affiliation>Islamic Azad University</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>At least two months have passed since the start of treatment
End of induction and stabilization period
Negative drug test
Having at least a high school diploma
Written consent to enter the research</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>60 years</agemax>
      <gender>Male</gender>
      <exclusion_criteria>Receiving other psychological interventions
Having or having a history of epilepsy or other brain diseases and psychosis
Mental retardation
Taking drugs or anti-anxiety drugs</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>F11.2</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Opioid dependence</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Devices</i_code>
      <i_code>Treatment - Other</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: experimental group A will receive ten sessions of transcranial electric current stimulation. Intervention with OASIS PRO WITH tDCS device from MIND ALIVE company was used. Subjects in this group participated in treatment sessions every other day for ten sessions. Anode electrode was placed in the posterolateral region of the left prefrontal cortex and cathode electrode was placed in the posterolateral region of the right prefrontal cortex, and in each session for 20 minutes, a current of 2 milliamps of direct electric current was passed through the skull of the subjects.</i_keyword>
      <i_keyword>Intervention group: The experimental group received ten sessions of cognitive rehabilitation, which used Nejati's cognitive rehabilitation computer program (2010), which includes strengthening working memory, strengthening selective attention, strengthening sustained attention, and strengthening transitional attention. It was performed in 10 sessions of 30 minutes and 3 sessions per week</i_keyword>
      <i_keyword>Control group: The control group will continue their usual treatment program and receive no other intervention</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Selective attention. Timepoint: Before the start of the intervention and at the end of the intervention. Method of measurement: Stroop test.</prim_outcome>
      <prim_outcome>Cognitive flexibility. Timepoint: Before the start of the intervention and at the end of the intervention. Method of measurement: Dennis and Vander Waal (2010) cognitive flexibility questionnaire (CFI).</prim_outcome>
      <prim_outcome>Response inhibition. Timepoint: Before the start of the intervention and at the end of the intervention. Method of measurement: go / no go test.</prim_outcome>
      <prim_outcome>Craving. Timepoint: Before the start of the intervention and at the end of the intervention. Method of measurement: Craving intensity test.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Islamic Azad University</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-06-21</approval_date>
        <contact_name>Islamic Azad University, Semnan branch</contact_name>
        <contact_address>Islamic Azad University, Semnan Branch, Faculty of Humanities, Department of Psychology Semnan Semnan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
